Novo Nordisk reported DKK78.49B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Bausch Health Companies USD 2.85B 350M Jun/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Eli Lilly USD 22.97B 3.17B Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Merck USD 16.6B 310M Jun/2026
Novartis USD 14.41B 1.3B Jun/2026
Novo Nordisk DKK 78.49B 18.33B Jun/2026
Novo Nordisk DKK 12.13B 84.69B Jun/2026
Pacira USD 192.4M 15.4M Jun/2026
Sanofi EUR 11.95B 710M Jun/2026
Supernus Pharmaceuticals USD 219.1M 11.39M Jun/2026